vs
Side-by-side financial comparison of ORTHOPEDIATRICS CORP (KIDS) and STEM, INC. (STEM). Click either name above to swap in a different company.
ORTHOPEDIATRICS CORP is the larger business by last-quarter revenue ($61.6M vs $47.1M, roughly 1.3× STEM, INC.). ORTHOPEDIATRICS CORP runs the higher net margin — -16.4% vs -33.9%, a 17.5% gap on every dollar of revenue. On growth, ORTHOPEDIATRICS CORP posted the faster year-over-year revenue change (17.0% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs 17.4%).
OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
KIDS vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $61.6M | $47.1M |
| Net Profit | $-10.1M | $-16.0M |
| Gross Margin | 73.2% | 48.9% |
| Operating Margin | -13.3% | -17.7% |
| Net Margin | -16.4% | -33.9% |
| Revenue YoY | 17.0% | -15.6% |
| Net Profit YoY | 37.1% | 68.8% |
| EPS (diluted) | $-0.43 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $61.6M | $47.1M | ||
| Q3 25 | $61.3M | $38.2M | ||
| Q2 25 | $61.1M | $38.4M | ||
| Q1 25 | $52.4M | $32.5M | ||
| Q4 24 | $52.7M | $55.8M | ||
| Q3 24 | $54.6M | $29.3M | ||
| Q2 24 | $52.8M | $34.0M | ||
| Q1 24 | $44.7M | $25.5M |
| Q4 25 | $-10.1M | $-16.0M | ||
| Q3 25 | $-11.8M | $-23.8M | ||
| Q2 25 | $-7.1M | $202.5M | ||
| Q1 25 | $-10.7M | $-25.0M | ||
| Q4 24 | $-16.1M | $-51.1M | ||
| Q3 24 | $-7.9M | $-148.3M | ||
| Q2 24 | $-6.0M | $-582.3M | ||
| Q1 24 | $-7.8M | $-72.3M |
| Q4 25 | 73.2% | 48.9% | ||
| Q3 25 | 73.9% | 35.5% | ||
| Q2 25 | 72.1% | 33.4% | ||
| Q1 25 | 73.0% | 32.4% | ||
| Q4 24 | 67.5% | -4.4% | ||
| Q3 24 | 73.4% | 21.2% | ||
| Q2 24 | 77.3% | 27.6% | ||
| Q1 24 | 72.0% | -95.0% |
| Q4 25 | -13.3% | -17.7% | ||
| Q3 25 | -15.4% | -33.6% | ||
| Q2 25 | -17.4% | -34.8% | ||
| Q1 25 | -21.0% | -65.0% | ||
| Q4 24 | -26.7% | -84.4% | ||
| Q3 24 | -10.2% | -493.2% | ||
| Q2 24 | -10.7% | -1705.5% | ||
| Q1 24 | -21.8% | -267.0% |
| Q4 25 | -16.4% | -33.9% | ||
| Q3 25 | -19.2% | -62.2% | ||
| Q2 25 | -11.6% | 527.8% | ||
| Q1 25 | -20.3% | -76.9% | ||
| Q4 24 | -30.5% | -91.6% | ||
| Q3 24 | -14.5% | -506.3% | ||
| Q2 24 | -11.4% | -1712.6% | ||
| Q1 24 | -17.5% | -283.9% |
| Q4 25 | $-0.43 | $-4.40 | ||
| Q3 25 | $-0.50 | $-2.84 | ||
| Q2 25 | $-0.30 | $-1.79 | ||
| Q1 25 | $-0.46 | $-0.15 | ||
| Q4 24 | $-0.70 | $-15.29 | ||
| Q3 24 | $-0.34 | $-18.24 | ||
| Q2 24 | $-0.26 | $-71.81 | ||
| Q1 24 | $-0.34 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $60.9M | $48.9M |
| Total DebtLower is stronger | $106.0M | — |
| Stockholders' EquityBook value | $346.6M | $-249.4M |
| Total Assets | $508.6M | $308.9M |
| Debt / EquityLower = less leverage | 0.31× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $60.9M | $48.9M | ||
| Q3 25 | $57.7M | $43.1M | ||
| Q2 25 | $70.1M | $40.8M | ||
| Q1 25 | $58.8M | $58.6M | ||
| Q4 24 | $68.8M | $56.3M | ||
| Q3 24 | $76.1M | $75.4M | ||
| Q2 24 | $28.9M | $89.6M | ||
| Q1 24 | $47.7M | $112.8M |
| Q4 25 | $106.0M | — | ||
| Q3 25 | $105.3M | — | ||
| Q2 25 | $102.7M | — | ||
| Q1 25 | $77.4M | — | ||
| Q4 24 | $77.5M | — | ||
| Q3 24 | $76.9M | — | ||
| Q2 24 | $11.2M | — | ||
| Q1 24 | $11.3M | — |
| Q4 25 | $346.6M | $-249.4M | ||
| Q3 25 | $349.3M | $-235.7M | ||
| Q2 25 | $355.5M | $-214.1M | ||
| Q1 25 | $347.1M | $-417.5M | ||
| Q4 24 | $354.6M | $-398.4M | ||
| Q3 24 | $370.9M | $-344.1M | ||
| Q2 24 | $371.3M | $-203.2M | ||
| Q1 24 | $370.6M | $371.6M |
| Q4 25 | $508.6M | $308.9M | ||
| Q3 25 | $493.5M | $362.6M | ||
| Q2 25 | $503.6M | $379.2M | ||
| Q1 25 | $470.3M | $405.1M | ||
| Q4 24 | $473.2M | $437.4M | ||
| Q3 24 | $489.3M | $537.8M | ||
| Q2 24 | $430.8M | $691.5M | ||
| Q1 24 | $437.2M | $1.3B |
| Q4 25 | 0.31× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.29× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.22× | — | ||
| Q3 24 | 0.21× | — | ||
| Q2 24 | 0.03× | — | ||
| Q1 24 | 0.03× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $10.3M | $8.2M |
| Free Cash FlowOCF − Capex | $9.7M | — |
| FCF MarginFCF / Revenue | 15.8% | — |
| Capex IntensityCapex / Revenue | 1.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.3M | $8.2M | ||
| Q3 25 | $-581.0K | $11.4M | ||
| Q2 25 | $-10.5M | $-21.3M | ||
| Q1 25 | $-4.2M | $8.5M | ||
| Q4 24 | $-4.0M | $-14.7M | ||
| Q3 24 | $-10.3M | $-9.4M | ||
| Q2 24 | $-6.1M | $-11.9M | ||
| Q1 24 | $-6.7M | $-621.0K |
| Q4 25 | $9.7M | — | ||
| Q3 25 | $-3.4M | — | ||
| Q2 25 | $-13.9M | — | ||
| Q1 25 | $-8.4M | — | ||
| Q4 24 | $-4.2M | — | ||
| Q3 24 | $-11.7M | — | ||
| Q2 24 | $-12.8M | — | ||
| Q1 24 | $-13.2M | — |
| Q4 25 | 15.8% | — | ||
| Q3 25 | -5.6% | — | ||
| Q2 25 | -22.8% | — | ||
| Q1 25 | -16.0% | — | ||
| Q4 24 | -8.1% | — | ||
| Q3 24 | -21.4% | — | ||
| Q2 24 | -24.2% | — | ||
| Q1 24 | -29.4% | — |
| Q4 25 | 1.0% | — | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 5.6% | — | ||
| Q1 25 | 8.1% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 12.7% | — | ||
| Q1 24 | 14.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
